RxSight, Inc.
RXST · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $529,669 | $1,022,869 | $1,387,465 |
| - Cash | $29,633 | $40,355 | $28,000 | $16,706 |
| + Debt | $10,272 | $11,715 | $12,042 | $12,296 |
| Enterprise Value | – | $501,029 | $1,006,911 | $1,383,055 |
| Revenue | $30,340 | $33,637 | $37,895 | $40,214 |
| % Growth | -9.8% | -11.2% | -5.8% | – |
| Gross Profit | $24,227 | $25,190 | $28,329 | $28,788 |
| % Margin | 79.9% | 74.9% | 74.8% | 71.6% |
| EBITDA | -$8,948 | -$10,964 | -$7,381 | -$5,398 |
| % Margin | -29.5% | -32.6% | -19.5% | -13.4% |
| Net Income | -$9,816 | -$11,786 | -$8,190 | -$5,938 |
| % Margin | -32.4% | -35% | -21.6% | -14.8% |
| EPS Diluted | -0.24 | -0.29 | -0.2 | -0.15 |
| % Growth | 17.2% | -45% | -33.3% | – |
| Operating Cash Flow | -$1,187 | -$4,376 | -$8,832 | -$4,260 |
| Capital Expenditures | -$581 | -$1,537 | -$575 | -$847 |
| Free Cash Flow | -$1,768 | -$5,913 | -$9,407 | -$5,107 |